| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | -15.17% | -1.47% | -13.70% | -13.70% | — |
| 14d | 2 | +100.00% | -14.08% | -1.20% | -12.88% | -12.88% | — |
| 30d | 2 | +50.00% | -13.40% | +3.06% | -16.46% | -16.46% | — |
| 60d | 2 | +100.00% | -49.09% | +1.85% | -71.56% | -71.56% | — |
| 90d | 2 | +100.00% | -53.23% | +10.48% | -63.71% | -63.71% | — |
| 180d | 2(1 pending) | +100.00% | -52.23% | +17.28% | -69.50% | -69.50% | — |
| 1y | 2(1 pending) | +100.00% | -36.81% | +13.45% | -50.26% | -50.26% | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KLRS KALARIS THERAPEUTICS, INC. | SALE Chief Accounting Officer | 1,915 | $6.72 | $12.9K | 0 | Mar 20, 2026 | Mar 23, 2026 ↗ | View → |
| KLRS KALARIS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,800 | — | — | 60,800 | Mar 19, 2026 | Mar 23, 2026 ↗ | View → |
| KLRS KALARIS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 50,262 | — | — | 50,262 | Apr 10, 2025 | Apr 11, 2025 ↗ | View → |
| KLRS KALARIS THERAPEUTICS, INC. | SALE Chief Accounting Officer | 907 | $8.97 | $8.1K | 1,925 | Mar 26, 2025 | Mar 27, 2025 ↗ | View → |